Find a Doctor
Jason Fleming, MD, FACS
Chair, Gastrointestinal OncologySpecialty: Surgery
Sub Specialty: General Surgery
Program: Gastrointestinal Oncology
Cancer Focus: Neuroendocrine Tumor, Pancreatic Cancer
Dr. Jason Fleming is chair and senior member of the Department of Gastrointestinal Oncology. Dr. Fleming is also a member of the Chemical Biology and Molecular Medicine Program. Dr. Fleming completed his medical degree at the University of Tennessee, Center of Health Science, Memphis, and his clinical residency in general surgery at the University of Texas Southwestern Medical Center, Dallas. Dr. Fleming completed two fellowships: a Cancer Research Fellowship at the University of Texas Southwestern Medical Center, Hamon Center for Therapeutic Oncology, Dallas, and a Clinical Fellowship in Surgical Oncology at the University of Texas MD Anderson Cancer Center, Houston. Prior to coming to Moffitt, Dr. Fleming was professor with tenure in the Department of Surgical Oncology at the University of Texas MD Anderson Cancer Center in Houston, where he served as chief of Pancreas Surgery and executive director of Perioperative Services. In addition to his academic and administrative responsibilities at MD Anderson, Dr. Fleming was co-director of the Pancreatic Cancer Moonshot Program, a Scientific and Medical Advisory board member for the Pancreatic Cancer Action Network (PanCAN), and a consultant for the Society of Abdominal Radiology Disease-Focused Panel. Dr. Fleming has served on numerous committees and holds an impressive array of honors and awards. He has been a Texas Super Doctor in Texas Monthly since 2011, and he has been featured in the Consumer Research Council of America’s Guide to America’s Top Surgeons every year since 2012. Dr. Fleming received the Castle Connolly Top Doctor award every year since 2013. He has been recognized for his outstanding research publications, and in 2016 he received the President’s Faculty Recognition Award for Outstanding Contribution to the University of Texas MD Anderson Cancer Center.
Education & Training
CLINICAL TRIAL 21065
If you believe you are eligible for one of these trials or studies, please call
Title: Induction of Innate and Adaptive Anti-Tumor Immunity Against Colorectal Liver Metastases
60 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. These surveys assess the experience of our patients when visiting us for an Outpatient Clinic, Urgent Care or Virtual Health (Telemedicine) visit. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.Learn more about our patient comments
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including: